ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
anieesh
|
23K |
13M |
18 |
10/06/20 |
10/06/20 |
ASX - By Stock
|
23K
|
13M
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
anieesh
|
17K |
6.5M |
6 |
09/06/20 |
09/06/20 |
ASX - By Stock
|
17K
|
6.5M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
anieesh
|
17K |
6.5M |
20 |
09/06/20 |
09/06/20 |
ASX - By Stock
|
17K
|
6.5M
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
anieesh
|
17K |
6.5M |
23 |
08/06/20 |
08/06/20 |
ASX - By Stock
|
17K
|
6.5M
|
23
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
anieesh
|
17K |
6.5M |
22 |
07/06/20 |
07/06/20 |
ASX - By Stock
|
17K
|
6.5M
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
anieesh
|
17K |
6.5M |
24 |
05/06/20 |
05/06/20 |
ASX - By Stock
|
17K
|
6.5M
|
24
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
anieesh
|
17K |
6.5M |
7 |
04/06/20 |
04/06/20 |
ASX - By Stock
|
17K
|
6.5M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Will Moderna Vaccine progress effect MSB SP?
|
|
anieesh
|
27 |
13K |
11 |
19/05/20 |
19/05/20 |
ASX - By Stock
|
27
|
13K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
anieesh
|
17K |
6.5M |
9 |
19/05/20 |
19/05/20 |
ASX - By Stock
|
17K
|
6.5M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
anieesh
|
17K |
6.5M |
4 |
10/05/20 |
10/05/20 |
ASX - By Stock
|
17K
|
6.5M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
anieesh
|
17K |
6.5M |
7 |
10/05/20 |
10/05/20 |
ASX - By Stock
|
17K
|
6.5M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
anieesh
|
17K |
6.5M |
5 |
09/05/20 |
09/05/20 |
ASX - By Stock
|
17K
|
6.5M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
anieesh
|
17K |
6.5M |
17 |
08/05/20 |
08/05/20 |
ASX - By Stock
|
17K
|
6.5M
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
anieesh
|
17K |
6.5M |
22 |
08/05/20 |
08/05/20 |
ASX - By Stock
|
17K
|
6.5M
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
anieesh
|
17K |
6.5M |
19 |
08/05/20 |
08/05/20 |
ASX - By Stock
|
17K
|
6.5M
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Ann: First Patients Dosed in Phase 2/3 Trial for COVID-19 ARDS
|
|
anieesh
|
188 |
77K |
5 |
06/05/20 |
06/05/20 |
ASX - By Stock
|
188
|
77K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: First Patients Dosed in Phase 2/3 Trial for COVID-19 ARDS
|
|
anieesh
|
188 |
77K |
7 |
06/05/20 |
06/05/20 |
ASX - By Stock
|
188
|
77K
|
7
|
|
ASX - By Stock
|
ECG |
Re:
Ann: Proxy Form
|
|
anieesh
|
2 |
1.3K |
0 |
05/05/20 |
05/05/20 |
ASX - By Stock
|
2
|
1.3K
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
anieesh
|
23K |
13M |
26 |
05/05/20 |
05/05/20 |
ASX - By Stock
|
23K
|
13M
|
26
|
|
ASX - By Stock
|
ECG |
Re:
Ann: Proxy Form
|
|
anieesh
|
2 |
1.3K |
0 |
05/05/20 |
05/05/20 |
ASX - By Stock
|
2
|
1.3K
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
anieesh
|
23K |
13M |
17 |
05/05/20 |
05/05/20 |
ASX - By Stock
|
23K
|
13M
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Confirmation Bias
|
|
anieesh
|
152 |
52K |
1 |
03/05/20 |
03/05/20 |
ASX - By Stock
|
152
|
52K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Confirmation Bias
|
|
anieesh
|
152 |
52K |
4 |
03/05/20 |
03/05/20 |
ASX - By Stock
|
152
|
52K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
The competition to Remestemcel-L in COVID-19
|
|
anieesh
|
159 |
59K |
4 |
03/05/20 |
03/05/20 |
ASX - By Stock
|
159
|
59K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
anieesh
|
17K |
6.5M |
6 |
03/05/20 |
03/05/20 |
ASX - By Stock
|
17K
|
6.5M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Confirmation Bias
|
|
anieesh
|
152 |
52K |
21 |
02/05/20 |
02/05/20 |
ASX - By Stock
|
152
|
52K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
anieesh
|
17K |
6.5M |
3 |
02/05/20 |
02/05/20 |
ASX - By Stock
|
17K
|
6.5M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Gilead vs Mesoblast
|
|
anieesh
|
274 |
109K |
7 |
01/05/20 |
01/05/20 |
ASX - By Stock
|
274
|
109K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Gilead vs Mesoblast
|
|
anieesh
|
274 |
109K |
19 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
274
|
109K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Gilead vs Mesoblast
|
|
anieesh
|
274 |
109K |
7 |
30/04/20 |
30/04/20 |
ASX - By Stock
|
274
|
109K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
MESO action tonight
|
|
anieesh
|
3.1K |
1.4M |
14 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
3.1K
|
1.4M
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C - quarterly
|
|
anieesh
|
203 |
93K |
2 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
203
|
93K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Valuation Musings
|
|
anieesh
|
64 |
37K |
11 |
29/04/20 |
29/04/20 |
ASX - By Stock
|
64
|
37K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
anieesh
|
17K |
6.5M |
7 |
28/04/20 |
28/04/20 |
ASX - By Stock
|
17K
|
6.5M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Closing Price today
|
|
anieesh
|
57 |
23K |
8 |
27/04/20 |
27/04/20 |
ASX - By Stock
|
57
|
23K
|
8
|
|
ASX - By Stock
|
QAN |
Re:
Trouble brewing
|
|
anieesh
|
20 |
9.9K |
3 |
20/04/20 |
20/04/20 |
ASX - By Stock
|
20
|
9.9K
|
3
|
|
ASX - By Stock
|
EVN |
Re:
EVN fundamentals
|
|
anieesh
|
11 |
7.3K |
1 |
12/04/20 |
12/04/20 |
ASX - By Stock
|
11
|
7.3K
|
1
|
|
ASX - By Stock
|
FLT |
Re:
Equity raise process
|
|
anieesh
|
97 |
40K |
0 |
12/04/20 |
12/04/20 |
ASX - By Stock
|
97
|
40K
|
0
|
|
ASX - By Stock
|
WEB |
Re:
Retail Entitlement Offer
|
|
anieesh
|
58 |
40K |
0 |
10/04/20 |
10/04/20 |
ASX - By Stock
|
58
|
40K
|
0
|
|
ASX - By Stock
|
GOR |
Re:
P/E Ratio
|
|
anieesh
|
14 |
4.2K |
2 |
18/03/20 |
18/03/20 |
ASX - By Stock
|
14
|
4.2K
|
2
|
|
ASX - By Stock
|
RSG |
Re:
last chance to get on board the gold train
|
|
anieesh
|
62 |
22K |
1 |
17/03/20 |
17/03/20 |
ASX - By Stock
|
62
|
22K
|
1
|
|
ASX - By Stock
|
NCM |
Re:
NCM chart
|
|
anieesh
|
654 |
1.6M |
3 |
17/03/20 |
17/03/20 |
ASX - By Stock
|
654
|
1.6M
|
3
|
|
ASX - By Stock
|
FFX |
Re:
Current SP and any other thoughts
|
|
anieesh
|
7.7K |
4.3M |
11 |
24/02/20 |
24/02/20 |
ASX - By Stock
|
7.7K
|
4.3M
|
11
|
|
ASX - By Stock
|
RSG |
Re:
RSG Needs Grand Plans and Visions
|
|
anieesh
|
56 |
63K |
2 |
23/02/20 |
23/02/20 |
ASX - By Stock
|
56
|
63K
|
2
|
|
ASX - By Stock
|
NCM |
Re:
News: NCM Papua New Guinea treasurer calls for more benefits from LNG, mining projects
|
|
anieesh
|
10 |
2.9K |
1 |
03/07/19 |
03/07/19 |
ASX - By Stock
|
10
|
2.9K
|
1
|
|
ASX - By Stock
|
NCM |
Re:
News: NCM Papua New Guinea treasurer calls for more benefits from LNG, mining projects
|
|
anieesh
|
10 |
2.9K |
0 |
03/07/19 |
03/07/19 |
ASX - By Stock
|
10
|
2.9K
|
0
|
|
ASX - By Stock
|
NCM |
Re:
News: NCM Papua New Guinea treasurer calls for more benefits from LNG, mining projects
|
|
anieesh
|
10 |
2.9K |
0 |
28/06/19 |
28/06/19 |
ASX - By Stock
|
10
|
2.9K
|
0
|
|
ASX - By Stock
|
NCM |
Re:
News: NCM LIVE MARKETS U.S.-Gold and gold miner Dynamic duo
|
|
anieesh
|
21 |
10K |
1 |
26/06/19 |
26/06/19 |
ASX - By Stock
|
21
|
10K
|
1
|
|
ASX - By Stock
|
SAR |
Re:
SAR Daily Price Discussion
|
|
anieesh
|
869 |
1.8M |
0 |
25/06/19 |
25/06/19 |
ASX - By Stock
|
869
|
1.8M
|
0
|
|
ASX - By Stock
|
FFX |
Re:
Mining permit
|
|
anieesh
|
20 |
13K |
15 |
25/06/19 |
25/06/19 |
ASX - By Stock
|
20
|
13K
|
15
|
|